Loading …
Loading Events

« All Events

Virtual Event Virtual Event
  • This event has passed.

Webinar: Key Considerations for ATMP Manufacturing Facilities

Virtual Event Virtual Event

May 10 @ 2:00 PM 3:00 PM

Advanced therapy medicinal products (ATMPs) span a wide range of technologies, from cell-free production of messenger RNA (mRNA) and DNA therapeutics to autologous or allogeneic cell therapies and viral vector induced gene therapies. This webinar will focus on the specific challenges of creating assets for the manufacture of ATMP therapeutics whose success hinges upon how well this cutting-edge science translates into facility and process design. A proactive planning approach helps biologic manufacturers expedite time to market while gaining flexibility, cost control, and predictive scalability.

Attendees of this webinar will gain insight into:

How to optimize their manufacturing from conceptual planning to construction and operations
How integrated project delivery vs. design-build can add value to your project
How to identify and mitigate special risks such as l formulation requirements, hazardous materials, or scale-out.



Jeffery Odum, CPIP
ATMP and Biologics Practice Lead
Genesis AEC

Jeffery Odum, CPIP, is a globally recognized SME, with 30 years of management experience in the design, construction, and start-up of facilities in the biotechnology and pharmaceutical industries. A recognized expert in biopharmaceutical manufacturing, Jeff has authored over eighty articles and four Industry reference books on subjects related to project management, GMP compliance, process improvement, and the design and construction of biopharmaceutical manufacturing facilities. He is a Certified Pharmaceutical Industry Professional (CPIP), the Chair of the ISPE global Biotechnology Community of Practice, a member of the PDA and ISPE technical training faculties, and a Teaching Fellow in North Carolina State University’s BTEC graduate program in biomanufacturing. Jeff has led training efforts in fifteen countries, including training for global regulators from the US FDA, Health Canada, and the Chinese SFDA. He holds a master’s degree in engineering from the University of Tennessee.